Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regulation of human glia by multiple sclerosis disease modifying therapies.
How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Computational modeling of cytokine signaling in microglia.
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
Assessing disability weights based on the responses of 30,660 people from four European countries.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.
Contribution of symptom clusters to multiple sclerosis consequences.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
[Detection of anti-aquaporin 4 antibody in neuromyelitis optica].
[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Established disease-modifying treatments in relapsing-remitting multiple sclerosis.
Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in Southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system.
6.7-kbp deletion in LILRA3 (ILT6) gene is associated with later onset of the multiple sclerosis in a Polish population.
16 Syndrome in a Patient With Multiple Sclerosis.
Neurogenic detrusor overactivity: an update on management options.

Pages